Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.
Pooled Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Screening Market Size Outlook: How Quickly Will Revenue Expand Through 2030?
The pooled clustered regularly interspaced short palindromic repeats (crispr) screening market size has experienced significant expansion recently. Its value is projected to rise from $1.3 billion in 2025 to $1.51 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 15.9%. This past growth can be attributed to an increasing need for functional genomics, wider adoption of CRISPR-Cas9 technology, an increase in pharmaceutical research and development, progress in gene editing tools, and the expansion of academic research programs.
The pooled clustered regularly interspaced short palindromic repeats (crispr) screening market is projected to experience substantial expansion over the upcoming years. This market is anticipated to reach a valuation of $2.74 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 16.1%. Factors contributing to this growth during the forecast period include AI-enabled gene screening, the integration of cloud-based genomics platforms, increasing demand for personalized medicine applications, the expansion of biotech infrastructure, and advancements in automation for high-throughput screening. Key trends identified for the forecast period encompass high-throughput screening techniques, the integration of multi-omics data, automated CRISPR workflows, AI-driven gene target identification, and real-time functional genomics analysis.
Get A Free Sample Report With In-Depth Market Insights:
Pooled Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Screening Market Growth Factors: What’s Supporting Expansion?
The growing occurrence of genetic disorders is anticipated to fuel the expansion of the pooled clustered regularly interspaced short palindromic repeats (CRISPR) screening market. These conditions, stemming from inherited or acquired DNA irregularities impacting normal bodily functions, are seeing an uptick in prevalence. This increase is partly due to factors such as older parental age, enhanced diagnostic tools, and broader genetic screening efforts, which collectively lead to more cases being identified and reported. Pooled CRISPR screening is vital for genetic disorder research, facilitating high-throughput, genome-wide discovery of genes and pathways linked to diseases. For instance, the Cystic Fibrosis Trust, a UK-based charity, noted in October 2024 that cystic fibrosis patient registrations increased from approximately 11,148 in 2022 to 11,318 in 2023, showing an annual growth of about 1.5%. Consequently, the rising incidence of genetic disorders is a key driver for the pooled clustered regularly interspaced short palindromic repeats (CRISPR) screening market.
Pooled Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Screening Market Segment Analysis Spotlighting Growth Areas
The pooled clustered regularly interspaced short palindromic repeats (crispr) screening market covered in this report is segmented –
1) By Screening Type: Genome Wide Screening, Targeted Screening
2) By Product Type: Libraries, Reagents And Kits, Instruments, Software, Services
3) By Technology: Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Cas9 Screening, Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Interference Screening, Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Activation Screening
4) By Application: Functional Genomics, Drug Discovery, Cancer Research, Gene Regulation, Other Applications
5) By End-User: Pharmaceutical And Biotechnology Companies, Academic And Research Institutes, Contract Research Organizations, Other End-Users
Subsegments:
1) By Genome Wide Screening: Knockout Screening, Activation Screening, Interference Screening
2) By Targeted Screening: Gene Specific Knockout, Gene Specific Activation, Gene Specific Interference
Pooled Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Screening Market Industry Trends: What’s Reshaping Demand?
Major companies in the pooled clustered regularly interspaced short palindromic repeats (CRISPR) screening market are concentrating on developing innovative solutions like transcriptome-wide profiling to enable high-throughput functional genomics and precise identification of gene targets for therapeutic and research applications. Transcriptome-wide profiling refers to the comprehensive analysis of all RNA transcripts expressed in a cell or tissue at a given time, providing insights into gene activity, regulation, and cellular functions. For instance, in June 2023, Parse Biosciences Inc., a US-based biotechnology company, launched CRISPR Detect, a technology enabling high-scale single-cell pooled CRISPR screens. This innovation integrates with the company’s Evercode Whole Transcriptome platform to pair individual gene perturbations, via Cas12-based single guide ribonucleic acid (RNA) (sgRNAs), with whole-transcriptome expression profiles across up to one million cells per experiment, overcoming prior throughput and cost barriers in droplet-based single-cell RNA-seq. It expands applications in genome-scale gene function analysis, regulatory networks, signaling pathways, and drug discovery beyond targeted validation.
Pooled Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Screening Market Key Participants And Competitive Landscape
Major companies operating in the pooled clustered regularly interspaced short palindromic repeats (crispr) screening market are Thermo Fisher Scientific Inc., Merck KGaA, Danaher Corporation, Applied Biological Materials Inc., Agilent Technologies Inc., Charles River Laboratories International Inc., QIAGEN N.V., GenScript Biotech Corporation, Twist Bioscience Corporation, Ginkgo Bioworks Inc., Element Biosciences Inc., Synthego Corporation, Bit.bio Limited, Bioneer Corporation, VectorBuilder Inc., Admera Health LLC, Addgene Inc., Creative Biogene Inc., Cellecta Inc., Vivlion Inc., GeneCopoeia Inc.
View The Full Pooled Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Screening Market Report:
Pooled Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Screening Market Geographic Analysis: Where Is Demand Rising Fastest?
North America was the largest region in the pooled clustered regularly interspaced short palindromic repeats (CRISPR) screening market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pooled clustered regularly interspaced short palindromic repeats (crispr) screening market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

